$1.60
0.138.45%
Last update: Nov 5, 1:53 PM
Lexicon Pharmaceuticals Inc
LXRXNASDAQ
The average analyst price target for Lexicon Pharmaceuticals is $4.85, 202.2% above the current price. Of 6 analysts, 4 rate it Buy and 2 Hold. Targets range from $1 to $8. The latest change came on Sep 28, 2026, when Cantor Fitzgerald initiated coverage of Lexicon Pharmaceuticals with an Overweight rating and a $8 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
